EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing

Noriyuki Kurimoto, Yu Nishida, Shuhei Hosomi iD, Shigehiro Itani, Yumie Kobayashi, Rieko Nakata, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Fumio Tanaka, Yasuaki Nagami und 3 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0280252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Noriyuki Kurimoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endoscopic mucosal healing (MH) is an important treatment goal for patients with ulcerative colitis (UC). The neutrophil-to-lymphocyte ratio (NLR) reflects systemic inflammation and has been reported to be a useful predictive marker for UC. This study aimed to evaluate the clinical utility of the NLR for predicting clinical relapse in UC patients with MH. We retrospectively enrolled patients with UC who underwent colonoscopy at the Osaka City University Hospital between January 2010 and December 2010, whose Mayo Endoscopic Subscore was 0 or 1. The correlation between the incidence of relapse and demographic factors, including the NLR, was analyzed. We included 129 patients in the present study. The median NLR at the time of endoscopy was 1.98, and differences in the high NLR group and the low NLR group were compared. During a median follow-up period of 46.4 months, 58 patients (45.0%) experienced relapse. The cumulative relapse-free rate was significantly higher in the low NLR group than in the high NLR group ( P = 0.03, log-rank test). Multivariate analysis identified high NLR as an independent prognostic factor for clinical relapse (hazard ratio, 1.74; 95% confidence interval, 1.02–2.98; P = 0.04). NLR is a novel and useful predictor of clinical relapse in UC patients with MH, and it can potentially be a strong indicator to determine the appropriate treatment strategy and decision-making in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHumansRetrospective StudiesNeutrophilsColonoscopyChronic DiseaseLymphocytesIntestinal MucosaSeverity of Illness IndexRecurrence

Autor:innen und Institutionen

  • Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

ORCID-Profile: Shuhei Hosomi

Zitieren

APA

Kurimoto, N., Nishida, Y., Hosomi, S., Itani, S., Kobayashi, Y., Nakata, R., Ominami, M., Nadatani, Y., Fukunaga, S., Otani, K., Tanaka, F., Nagami, Y., Taira, K., Kamata, N., & Fujiwara, Y. (2023). Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing. PLOS ONE. https://doi.org/10.1371/journal.pone.0280252

Vancouver

Kurimoto N, Nishida Y, Hosomi S, Itani S, Kobayashi Y, Nakata R, et al. Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing. PLOS ONE. 2023. doi:10.1371/journal.pone.0280252

BibTeX
@article{Kurimoto2023,
  author = {Kurimoto, Noriyuki and Nishida, Yu and Hosomi, Shuhei and Itani, Shigehiro and Kobayashi, Yumie and Nakata, Rieko and Ominami, Masaki and Nadatani, Yuji and Fukunaga, Shusei and Otani, Koji and Tanaka, Fumio and Nagami, Yasuaki and Taira, Koichi and Kamata, Noriko and Fujiwara, Yasuhiro},
  title = {Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0280252}
}
Kostenlos starten →